Literature DB >> 7511458

Haemophilus influenzae: the efficiency of reporting invasive disease in England and Wales.

C A Macleod1.   

Abstract

This study compares the efficiency of a special regional survey with routine laboratory reporting to measure the incidence of invasive disease caused by Haemophilus influenzae before routine immunisation against type b strains was introduced. Incomplete reporting does not prevent the monitoring of trends, but it becomes important if the level of underreporting changes with time. This study illustrates the importance of assessing the quality of surveillance data before using them to inform policy or evaluate intervention. Underreporting to the regional survey was found to be 17% and underreporting to the Public Health Laboratory Service (PHLS) Communicable Disease Surveillance Centre (CDSC) was 24%. In response to this study a system has been set up to send reference laboratories a weekly list of reports to CDSC. Manual cross checking helps to complete the ascertainment of cases. All isolates of H. influenzae from cases of invasive disease should be sent to the reference laboratories for serotyping as well as being reported to CDSC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511458

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Rev        ISSN: 1350-9349


  3 in total

1.  Decrease in effectiveness of routine surveillance of Haemophilus influenzae disease after introduction of conjugate vaccine: comparison of routine reporting with active surveillance system.

Authors:  B Olowokure; J Hawker; I Blair; N Spencer
Journal:  BMJ       Date:  2000-09-23

2.  A secure protocol for protecting the identity of providers when disclosing data for disease surveillance.

Authors:  Khaled El Emam; Jun Hu; Jay Mercer; Liam Peyton; Murat Kantarcioglu; Bradley Malin; David Buckeridge; Saeed Samet; Craig Earle
Journal:  J Am Med Inform Assoc       Date:  2011-05-01       Impact factor: 4.497

3.  Physician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak.

Authors:  Khaled El Emam; Jay Mercer; Katherine Moreau; Inese Grava-Gubins; David Buckeridge; Elizabeth Jonker
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.